The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for January 19, 2018
Copyright © Brakke Consulting, Inc.

Editor: Lynn Fondon DVM MBA

Brakke Consulting news
Brakke merger with Stonehaven Consulting
Multi-client studies
2018 Industry Overview – register now for VMX

earnings news

other news
American Veterinarian
Atlantic Coast Veterinary Conference
Croda International
Lumosa Therapeutics
Merrick Pet Care
Nautilus Biosciences Canada
Nestlé Purina PetCare
Prevtec Microbia
Skyline Vet Pharma
Zuke’s Pet Nutrition


Brakke Consulting is pleased to announced it is merging with Switzerland-based Stonehaven Consulting.  Stonehaven Consulting was founded in 2015 by George Gunn, former CEO of Novartis AH, and has a global client base consisting of life science companies. The combination of the two companies will greatly increase the capacity and capability of both firms, and result in expanded services and geographical support for our clients. Stonehaven expects that the transaction will close on or before the end of Q1 2018.  For more information, visit our website at:


  • Virbac reported financial results for the full year 2017. Annual sales totaled EUR 862 million ($1,033 million), a decline of 1% compared to the prior year (-0.6% at constant exchange rates).  (company website)


Brakke Consulting is pleased to announce the 2018 Industry Overview. The 2018 US Animal Health Industry Overview will be presented twice this winter – once at the VMX (formerly NAVC) in Orlando, Florida and once at the Western Veterinary Conference in Las Vegas, Nevada. These dates are:
• VMX: Monday, February 5, 2018, 2:00 – 4:00 pm, Rosen Plaza Hotel
• WVC: Tuesday, March 6, 2018, 2:00 – 4:00 pm, Four Seasons.

Registration for the VMX Industry Overview is now open; registration for the WVC Industry overview will open in January. Seating is limited this year, so register early!

To register, go to and scroll down to the “What’s New” box. The price is $400 per person for online registration; late registration is $450.


  • Merck Animal Health announced that Safe-Guard AquaSol (fenbendazole oral suspension), is now approved for use in laying hens and replacement chickens intended to become laying hens. (company press release)

  • Innventure and Elanco Animal Health announced a strategic initiative to explore the development of technologies for animal health. The collaboration builds upon Innventure’s model, which identifies promising enterprise technologies and then develops and scales them in external startups. Terms were not disclosed. (Business Insider)

  • Prevtec Microbia announced that it has received a market authorization from the USDA’s Center for Veterinary Biologics to commercialize its vaccine Coliprotec F4 in the US, a front line product against post weaning diarrhea (PWD) in pigs. (

  • Lumosa Therapeutics, a new drug development company in Taiwan, and Skyline Vet Pharma (SVP) announced a licensing agreement for Lumosa’s CS011. According to the terms, SVP will develop and commercialize CS011, an extended-release analgesic injection, in North America, Australia and New Zealand for pain management in companion animals. Financial terms were not disclosed. (Business Insider)

  • Zuke’s Pet Nutrition and Merrick Pet Care announced that the companies are merging. Zuke’s is currently based in Durango, Colo., and will continue to have a presence there as an innovation hub; other business functions will be consolidated within Merrick Pet Care. Both Zuke’s and Merrick are a part of Nestlé Purina PetCare Company. (Pet Product News)

  • Worldwise, announced it has acquired PetEgo, LLC, makers of travel and lifestyle pet products. Financial terms were not disclosed. (Pet Age)

  • JBS S.A. announced that its subsidiary, JBS USA Food Co., has entered into an agreement to sell the totality of Five Rivers Cattle Feeding’s feedlot operations in the U.S. to affiliates of Pinnacle Asset Management LP for approximately $200 million. Pinnacle also agreed to sign a long-term contract to supply cattle to JBS in North America. (Feedstuffs)

  • Michael J. Hennessy Associates’ American Veterinarian, a comprehensive clinical information platform, announced it has acquired the Atlantic Coast Veterinary Conference (ACVC), broadening its leadership position in veterinary medicine by offering continuing education, live events and breaking news. Financial terms were not disclosed. (

  • EU Zoetis announced the European launch of Suvaxyn PRRS MLV, a modified live PRRS vaccine that provides protection from the first day of a pig’s life. The vaccine is also approved for gilts and sows, affording protection to the whole herd. Suvaxyn PRRS MLV contains a European PRRS virus strain (genotype 1). (Animal Pharm)

  • CANADA UK-based Croda International announced it has acquired Nautilus Biosciences Canada, a marine biotechnology business based in Prince Edward Island (PEI), Canada. Nautilus is focused on the discovery and development of marine-derived natural products for both human and animal health.  Financial terms were not disclosed. (Animal Pharm)


  • JAPAN – AVIAN INFLUENZA Japan confirmed its first highly pathogenic avian influenza case in livestock this winter at a poultry farm in Kagawa Prefecture. The government plans to cull around 91,000 chickens on the farm, and a quarantine zone has been set up around the farm. (japan times)

  • US – PORK IMPORTS The USDA finalized a regulation that will allow all Mexican states to export pork to the US. USDA’s APHIS concluded in 2016 that the risk of Classical Swine Fever (CSF), highly contagious viral disease, from pork imports from Mexico is negligible. CSF was eradicated from the US in the late 1970s. (Feedstuffs)

  • US – CANNABIS RESOURCE The AVMA has published a resource about cannabis. The document provides comprehensive background information to help veterinarians understand the legal aspects of cannabis use in animals; field questions and advise clients who are interested in marijuana therapies for their pets; and identify toxic exposures. Cannabis: What Veterinarians Need to Know is available exclusively to AVMA members. (AVMA)


Brakke Consulting is an industry leader in timely market research on topics of high interest to stakeholders in the animal health, pet and veterinary markets.  Reports published in the past year include:

  • Equine Mega Study IV (January 2018)
  • Distributor Effectiveness Study (December 2018)
  • US Flea Control and Heartworm Markets (December 2017)
  • US Companion Animal Veterinary Technical Services Study (biannual report coming in March 2018)
  • Pain Management Products for Dogs and Cats (annual report coming in April 2018)
  • Cancer in Dogs and Cats (2017)
  • New Strategies for Health & Performance in US Livestock & Poultry Production (2017)
  • Manufacturer Sales Force Effectiveness Study (biannual report)

Prices for reports vary. For more information about these or other reports, visit our website at or contact us at

It has been an interesting week at Brakke Consulting.  Almost every week I comment on the various acquisitions and divestitures taking place in the industry.  This week is no different with 6 transactions being report along with several out-licensing agreements.  However, this week was different in that Brakke Consulting was one of the companies that has agreed to be acquired and merged into Stonehaven Consulting.

In recent years a number of you have asked me when I was going to either find a purchaser for Brakke Consulting or hand the management reins over to another individual.  I can assure you that I have explored many of these alternatives extensively, but when I started interfacing with the Stonehaven management team, the decision became clear.  Both companies’ business objectives are to provide quality consulting services to the global animal health, pet, veterinary and nutrition industry. We believe these objectives can best be accomplished  by merging the two firms.

Both parties expect the closing to occur on or before March 31, 2018. I personally look forward to assisting in the integration of the two firms over the coming months and continuing to be a part of Stonehaven for at least the next year, if not longer. I expect to continue to interface with many of you for the foreseeable future.

I want to take this opportunity to thank all of our present and past clients, consultants and staff that have supported Brakke Consulting for the 31+ years we’ve been in business.  Your support has been vital to our success and allowed us to make many positive contributions to the industry.

Have a great weekend!

Ron Brakke


Trouble viewing this newsletter?  You can view it online at

This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.

For more information about Brakke Consulting’s services and syndicated studies, visit our website at

Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX  75234    USA


en_USEnglish (United States)